摘要
目的:研究一类新型的三氮唑化合物对念珠菌属真菌的抗真菌活性。方法:采用体外抗真菌活性试验, 测定化合物的最低抑菌浓度( M I C),从而评价化合物的生物活性作用。结果:所有24 个新的化合物对念珠菌属真菌均有不同的抑制作用,其中对白念珠菌的活性最好。化合物 12 对白念珠菌的活性最强,是标准对照品氟康唑的256 倍。化合物17 对耐氟康唑的白念珠菌的活性最强,是标准对照品氟康唑的16 倍。结论:化合物 12 和17 可以作为两个潜在的药物进一步进行研究。
Objective: To study the antifungal activity of the new triazole compounds against candida species . Methods: The MICs of new triazole compounds were determined in in vitro antifungal tests to evaluate the activities of title compounds. Results: All new triazole compounds had activity against candida species , especially high activity against candida albicans . Compound 12 exhibited remarkably high efficacy and was 256 times more active than fluconazole against candida albicans . Compound 17 was the most effective agent against fluconazole resistant candida albicans and was 16 times more active than fluconazole. Conclusion: The 2 compounds are worth advanced studying as potential drugs.
出处
《第二军医大学学报》
CAS
CSCD
北大核心
1999年第9期654-656,共3页
Academic Journal of Second Military Medical University
基金
军队"九五"医药科研规划重点课题